Vice President, Clinical Pharmacology, Pharmacometrics and DMPK jobs in United States
cer-icon
Apply on Employer Site
company-logo

Disc Medicine · 3 months ago

Vice President, Clinical Pharmacology, Pharmacometrics and DMPK

Disc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious hematologic diseases. The Vice President of Clinical Pharmacology, Pharmacometrics and DMPK will lead the integration of these functions into the R&D strategy and drive critical development and regulatory decisions across the pipeline.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Responsibilities

Further establish and lead the Clinical Pharmacology, Pharmacometrics and DMPK function. Define strategic vision, operational frameworks, and best practices tailored to Disc Medicine’s portfolio and R&D goals
Lead the clinical pharmacology and DMPK on cross-functional R&D teams, contributing to nonclinical and clinical development plans, study protocols, and decision-making at all stages
Apply quantitative methodologies—including population PK/PD, exposure–response modeling, PBPK, and QSP—to inform dose selection, clinical trial design, special population strategies, and regulatory submissions
Drive the clinical pharmacology and DMPK strategy for INDs, CTAs, NDAs/BLAs. Oversee related authorship and review of key regulatory documents and engagement with global health authorities
Collaborate closely with Clinical Development, Regulatory Affairs, CMC, Innovation, Toxicology, and Biomarker teams to ensure alignment and integration of Clinical Pharmacology and DMPK throughout R&D
Maintain expertise in evolving clinical pharmacology and pharmacometrics, and DMPK approaches. Represent Disc Medicine in external scientific forums, regulatory meetings, and industry collaborations

Qualification

Clinical PharmacologyDMPKPharmaceutical SciencesModelingSimulationRegulatory FilingsLeadership ExperienceCollaborationCommunication Skills

Required

PhD or PharmD in Clinical Pharmacology, DMPK, Pharmaceutical Sciences, or a related scientific discipline
20+ years of relevant industry experience, including 10+ years in a leadership capacity within clinical pharmacology and/or DMPK
Track record of supporting research and development programs including leading Clinical pharmacology/DMPK in regulatory filings and successful interactions with global health authorities
Expertise in a broad range of Clinical Pharmacology and DMPK areas with comprehensive understand of the applications of modeling and simulation methodologies (e.g., popPK, PBPK, exposure–response, QSP)
Demonstrated ability to work collaboratively in a cross-functional, matrixed environment and to influence at all levels of the organization
Excellent communication skills, including the ability to distill complex scientific analyses into clear, actionable recommendations

Benefits

Comprehensive benefits
Competitive compensation packages

Company

Disc Medicine

twittertwittertwitter
company-logo
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Funding

Current Stage
Public Company
Total Funding
$1.29B
Key Investors
Hercules CapitalFrazier Life SciencesBain Capital Life Sciences
2025-10-21Post Ipo Secondary· $25M
2025-10-21Post Ipo Equity· $225M
2025-01-22Post Ipo Equity· $225.5M

Leadership Team

leader-logo
John Quisel
Chief Executive Officer
linkedin
leader-logo
Jean Franchi
Chief Financial Officer
linkedin
Company data provided by crunchbase